Mast Cells are Dependent on Glucose Transporter 1 (GLUT1) and GLUT3 for IgE-mediated Activation
Inflammation · 2024-10 · 47 (5) · 1820-1836
DOI: 10.1007/s10753-024-02011-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammation, online erschienen am 03.04.2024. Verfasst von Mirjana Grujic und 4 weiteren Autor:innen. Beteiligte Einrichtung: Uppsala University, Department of Medical Biochemistry and Microbiology, Uppsala, Sweden. Hauptthemen laut MEDLINE: Glucose Transporter Type 3, Mast Cells, Glucose Transporter Type 1, Immunoglobulin E. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Knut och Alice Wallenbergs Stiftelse, Cancerfonden.
Abstract (Originalsprache)
Mast cells (MCs) are known to have a pathological impact in a variety of settings, in particular in allergic conditions. There is also limited evidence implicating MCs in diabetes, raising the possibility that MC function may be influenced by alterations in glucose levels. However, it is not known whether MCs are directly affected by elevated glucose concentrations. Moreover, it is not known which glucose transporters that are expressed by MCs, and whether MCs are dependent on glucose transporters for activation. Here we addressed these issues. We show that MCs express high levels of both glucose transporter 1 (GLUT1/Slc2A1) and GLUT3 (Slc2A3). Further, we show that the inhibition of either GLUT1 or GLUT3 dampens both MC degranulation and cytokine induction in response to IgE receptor crosslinking, and that combined GLUT1 and GLUT3 inhibition causes an even more pronounced inhibition of these parameters. In contrast, the inhibition of GLUT1 or GLUT3, or combined GLUT1 and GLUT3 inhibition, had less impact on the ability of the MCs to respond to activation via compound 48/80. Elevated glucose concentrations did not affect MC viability, and had no stimulatory effect on MC responses to either IgE receptor crosslinking or compound 48/80. Altogether, these findings reveal that MCs are strongly dependent on glucose transport via GLUT1 and/or GLUT3 for optimal responses towards IgE-mediated activation, whereas MC functionality is minimally affected by elevated glucose levels. Based on these findings, antagonists of GLUT1 and GLUT3 may be considered for therapeutic intervention in allergic conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Uppsala University, Department of Medical Biochemistry and Microbiology, Uppsala, Sweden.
- Uppsala University, Department of Medical Biochemistry and Microbiology, Uppsala, Sweden. alimab531@gmail.com.
- Uppsala University, Department of Public Health and Caring Sciences, General Medicine, Uppsala, Sweden. alimab531@gmail.com.
- University of Cambridge, Division of Immunology, Department of Pathology, Cambridge, UK. alimab531@gmail.com.
- Uppsala University, Department of Cell and Molecular Biology, Uppsala, Sweden.
- Uppsala University, Department of Public Health and Caring Sciences, General Medicine, Uppsala, Sweden.
Förderung
- Vetenskapsrådet
- Knut och Alice Wallenbergs Stiftelse
- Cancerfonden
- Hjärt-Lungfonden
- Familjen Erling-Perssons Stiftelse
- Uppsala University
Zitieren
APA
Grujic, M., Alim, M. A., Hellman, L., Peterson, M., & Pejler, G. (2024). Mast Cells are Dependent on Glucose Transporter 1 (GLUT1) and GLUT3 for IgE-mediated Activation. Inflammation, 47(5), 1820-1836. https://doi.org/10.1007/s10753-024-02011-8
Vancouver
Grujic M, Alim MA, Hellman L, Peterson M, Pejler G. Mast Cells are Dependent on Glucose Transporter 1 (GLUT1) and GLUT3 for IgE-mediated Activation. Inflammation. 2024;47(5):1820-1836. doi:10.1007/s10753-024-02011-8
BibTeX
@article{Grujic2024,
author = {Grujic, Mirjana and Alim, Md Abdul and Hellman, Lars and Peterson, Magnus and Pejler, Gunnar},
title = {Mast Cells are Dependent on Glucose Transporter 1 (GLUT1) and GLUT3 for IgE-mediated Activation},
journal = {Inflammation},
year = {2024},
volume = {47},
number = {5},
pages = {1820--1836},
doi = {10.1007/s10753-024-02011-8}
}
EUVIMED